Davis Polk advised the joint book-running managers and representatives of the underwriters on an SEC-registered offering by Stanley Black & Decker, Inc. of $500 million aggregate…
Davis Polk advised the representatives of the several underwriters in connection with the registered offering by DXC Technology Company of €650 million aggregate principal amount of 1…
Davis Polk advised the sole book-running manager in connection with a registered offering by Infinera Corporation of $402.5 million aggregate principal amount of 2.125% convertible…
Davis Polk advised the representatives of the underwriters in connection with the $175.5 million offering of 2,700,000 shares of common stock of REGENXBIO Inc. The common stock is listed on…
Davis Polk advised Banco Santander, S.A. in connection with the establishment of a $20 billion U.S. commercial paper program through its New York Branch. The commercial paper notes under…
Davis Polk advised the Province of New Brunswick in connection with the offering of $500 million aggregate principal amount of 3.625% bonds due February 24, 2028.
The Davis Polk team…
Davis Polk advised the underwriter in connection with the $56.6 million secondary offering of 2,200,000 shares of common stock of TriState Capital Holdings, Inc. by selling…
Davis Polk advised the joint book-running managers and several other underwriters in connection with SEC-registered offerings of 12,669,491 shares of common stock (which included 1,652,542…
Davis Polk advised the representatives of the underwriters in connection with the $175 million public offering by Cellectis S.A. of 5,646,000 American Depositary Shares, each representing…
Davis Polk advised Charles River Laboratories International, Inc. in connection with its Rule 144A/Regulation S offering of $500 million aggregate principal amount of 5.500% senior notes…